BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9245080)

  • 21. [Association between Class I HLA alleles and HBs antigen carrier status among blood donors in Senegal].
    Dieye A; Obami-Itou V; Barry MF; Raphenon G; Thiam A; Ndiaye R; Ndiaye M; Diaw ML; Diakhate L
    Dakar Med; 1999; 44(2):166-70. PubMed ID: 11957279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How specific MHC class I and class II combinations affect disease resistance against infectious salmon anaemia in Atlantic salmon (Salmo salar).
    Kjøglum S; Larsen S; Bakke HG; Grimholt U
    Fish Shellfish Immunol; 2006 Oct; 21(4):431-41. PubMed ID: 16616518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenetic factors in mycosis fungoides: can the HLA system influence the susceptibility and prognosis of the disease? Long-term follow-up study of 46 patients.
    Brazzelli V; Rivetti N; Badulli C; Carugno A; Grasso V; De Silvestri A; Martinetti M; Borroni G
    J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1732-7. PubMed ID: 24533560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of human leukocyte antigen in the pathogenesis of Ménière's disease in the South Korean population.
    Yeo SW; Park SN; Jeon EJ; Lee HY; Pyo CW; Kim TG
    Acta Otolaryngol; 2002 Dec; 122(8):851-6. PubMed ID: 12542204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between human leukocytes antigen alleles and chronic hepatitis C virus infection in the Korean population.
    Yoon SK; Han JY; Pyo CW; Yang JM; Jang JW; Kim CW; Chang UI; Bae SH; Choi JY; Chung KW; Sun HS; Choi HB; Kim TG
    Liver Int; 2005 Dec; 25(6):1122-7. PubMed ID: 16343061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Affected sib-pair analysis of the contribution of HLA class I and class II loci to development of cervical cancer.
    Engelmark M; Beskow A; Magnusson J; Erlich H; Gyllensten U
    Hum Mol Genet; 2004 Sep; 13(17):1951-8. PubMed ID: 15238505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA genotype and development of gastric cancer in patients with Helicobacter pylori infection.
    Hirata I; Murano M; Ishiguro T; Toshina K; Wang FY; Katsu K
    Hepatogastroenterology; 2007 Jun; 54(76):990-4. PubMed ID: 17629023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of extrahepatic manifestations with HLA class II alleles and with virus genotype in HCV infected patients.
    Sebastiani GD; Bellisai F; Caudai C; Rottoli P; Valensin PE; Pippi L; Morozzi G; Porciello G; Donvito A; Bilenchi R; Giannini F; Galeazzi M
    J Biol Regul Homeost Agents; 2005; 19(1-2):17-22. PubMed ID: 16180280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The HLA gene system].
    Abramov VIu
    Gematol Transfuziol; 1993 Apr; 38(4):25-7. PubMed ID: 8026669
    [No Abstract]   [Full Text] [Related]  

  • 30. IgA serum levels and HLA complement markers in gastric cancer patients.
    De Paoli F; Salerno-Mele P; Ranzani GN; Mazzucco M; Belvedere MC
    Cancer Detect Prev; 1988; 12(1-6):389-93. PubMed ID: 3180138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunogenetic aspects of duodenal ulcer in Helicobacter pylori positive Europeans in Western Siberia].
    Kurilovich SA; Konenkov VI; Shlykova LG; Prokof'ev VF
    Ter Arkh; 2001; 73(2):13-7. PubMed ID: 11338846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenetic risk factors of dilated cardiomyopathy.
    Popovici M; Groppa L; Kalinina L
    Blood Press Suppl; 1996; 3():49-52. PubMed ID: 8973770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The HLA system].
    Iazdovskiĭ VV
    Gematol Transfuziol; 1991 Jul; 36(7):30-5. PubMed ID: 1718811
    [No Abstract]   [Full Text] [Related]  

  • 34. Nomenclature for factors of the HLA system, 1989.
    Vox Sang; 1990; 58(2):140-9. PubMed ID: 2111062
    [No Abstract]   [Full Text] [Related]  

  • 35. HLA and disease association: the case of gastric cancer.
    Rigas B
    Gastroenterology; 1996 Aug; 111(2):523-6. PubMed ID: 8690220
    [No Abstract]   [Full Text] [Related]  

  • 36. [The immunogenetic heterogeneity of chronic glomerulonephritis].
    Karazhanova LK
    Ter Arkh; 1995; 67(8):5-7. PubMed ID: 7482336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The immunogenetic risk factors in the nephrotic syndrome].
    Shishkin AN; Ashirova KV; Balliuzek MF; Volovnikova VA
    Ter Arkh; 1994; 66(6):32-4. PubMed ID: 7940362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunogenetic aspects of pathogenesis, prognosis and treatment of the main forms of chronic pancreatitis].
    Gubergrits NB; Khodakovskii AV; Linevskii IV
    Klin Med (Mosk); 1996; 74(7):26-8. PubMed ID: 8992107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenetic characteristics of patients with stomach cancer and predominant activity of either sympathetic or parasympathetic autonomic nervous system.
    Abramov VV; Konenkov VI; Egorov DN; Korotkova IYu ; Solov'eva IG; Vardosanidze KV; Kozlov VA
    Dokl Biol Sci; 2000; 373():415-6. PubMed ID: 11013848
    [No Abstract]   [Full Text] [Related]  

  • 40. [The clinical immunogenetics of viral hepatitis C in a Caucasoid population of western Siberia].
    Tolokonskaia NP; Konenkov VI
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (3):78-80. PubMed ID: 10925885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.